img

Global Prucalopride Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Prucalopride Market Research Report 2024

Prucalopride is indicated for the treatment of chronic idiopathic constipation (CIC) in adults.
According to Mr Accuracy reports’s new survey, global Prucalopride market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Prucalopride market research.
Key manufacturers engaged in the Prucalopride industry include Takeda, Johnson & Johnson, Apotex Corporation and Jamp Pharma Corporation, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Prucalopride were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Prucalopride market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Prucalopride market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Takeda
Johnson & Johnson
Apotex Corporation
Jamp Pharma Corporation
Segment by Type
1 mg
2 mg

Segment by Application


Offline Channel
Online Channel

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Prucalopride report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Prucalopride Market Overview
1.1 Product Overview and Scope of Prucalopride
1.2 Prucalopride Segment by Type
1.2.1 Global Prucalopride Market Value Comparison by Type (2024-2034)
1.2.2 1 mg
1.2.3 2 mg
1.3 Prucalopride Segment by Application
1.3.1 Global Prucalopride Market Value by Application: (2024-2034)
1.3.2 Offline Channel
1.3.3 Online Channel
1.4 Global Prucalopride Market Size Estimates and Forecasts
1.4.1 Global Prucalopride Revenue 2018-2034
1.4.2 Global Prucalopride Sales 2018-2034
1.4.3 Global Prucalopride Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Prucalopride Market Competition by Manufacturers
2.1 Global Prucalopride Sales Market Share by Manufacturers (2018-2023)
2.2 Global Prucalopride Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Prucalopride Average Price by Manufacturers (2018-2023)
2.4 Global Prucalopride Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Prucalopride, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prucalopride, Product Type & Application
2.7 Prucalopride Market Competitive Situation and Trends
2.7.1 Prucalopride Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Prucalopride Players Market Share by Revenue
2.7.3 Global Prucalopride Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Prucalopride Retrospective Market Scenario by Region
3.1 Global Prucalopride Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Prucalopride Global Prucalopride Sales by Region: 2018-2034
3.2.1 Global Prucalopride Sales by Region: 2018-2023
3.2.2 Global Prucalopride Sales by Region: 2024-2034
3.3 Global Prucalopride Global Prucalopride Revenue by Region: 2018-2034
3.3.1 Global Prucalopride Revenue by Region: 2018-2023
3.3.2 Global Prucalopride Revenue by Region: 2024-2034
3.4 North America Prucalopride Market Facts & Figures by Country
3.4.1 North America Prucalopride Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Prucalopride Sales by Country (2018-2034)
3.4.3 North America Prucalopride Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Prucalopride Market Facts & Figures by Country
3.5.1 Europe Prucalopride Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Prucalopride Sales by Country (2018-2034)
3.5.3 Europe Prucalopride Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prucalopride Market Facts & Figures by Country
3.6.1 Asia Pacific Prucalopride Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Prucalopride Sales by Country (2018-2034)
3.6.3 Asia Pacific Prucalopride Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Prucalopride Market Facts & Figures by Country
3.7.1 Latin America Prucalopride Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Prucalopride Sales by Country (2018-2034)
3.7.3 Latin America Prucalopride Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Prucalopride Market Facts & Figures by Country
3.8.1 Middle East and Africa Prucalopride Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Prucalopride Sales by Country (2018-2034)
3.8.3 Middle East and Africa Prucalopride Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prucalopride Sales by Type (2018-2034)
4.1.1 Global Prucalopride Sales by Type (2018-2023)
4.1.2 Global Prucalopride Sales by Type (2024-2034)
4.1.3 Global Prucalopride Sales Market Share by Type (2018-2034)
4.2 Global Prucalopride Revenue by Type (2018-2034)
4.2.1 Global Prucalopride Revenue by Type (2018-2023)
4.2.2 Global Prucalopride Revenue by Type (2024-2034)
4.2.3 Global Prucalopride Revenue Market Share by Type (2018-2034)
4.3 Global Prucalopride Price by Type (2018-2034)
5 Segment by Application
5.1 Global Prucalopride Sales by Application (2018-2034)
5.1.1 Global Prucalopride Sales by Application (2018-2023)
5.1.2 Global Prucalopride Sales by Application (2024-2034)
5.1.3 Global Prucalopride Sales Market Share by Application (2018-2034)
5.2 Global Prucalopride Revenue by Application (2018-2034)
5.2.1 Global Prucalopride Revenue by Application (2018-2023)
5.2.2 Global Prucalopride Revenue by Application (2024-2034)
5.2.3 Global Prucalopride Revenue Market Share by Application (2018-2034)
5.3 Global Prucalopride Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Takeda
6.1.1 Takeda Corporation Information
6.1.2 Takeda Description and Business Overview
6.1.3 Takeda Prucalopride Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Takeda Prucalopride Product Portfolio
6.1.5 Takeda Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Prucalopride Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson & Johnson Prucalopride Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Apotex Corporation
6.3.1 Apotex Corporation Corporation Information
6.3.2 Apotex Corporation Description and Business Overview
6.3.3 Apotex Corporation Prucalopride Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Apotex Corporation Prucalopride Product Portfolio
6.3.5 Apotex Corporation Recent Developments/Updates
6.4 Jamp Pharma Corporation
6.4.1 Jamp Pharma Corporation Corporation Information
6.4.2 Jamp Pharma Corporation Description and Business Overview
6.4.3 Jamp Pharma Corporation Prucalopride Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Jamp Pharma Corporation Prucalopride Product Portfolio
6.4.5 Jamp Pharma Corporation Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prucalopride Industry Chain Analysis
7.2 Prucalopride Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prucalopride Production Mode & Process
7.4 Prucalopride Sales and Marketing
7.4.1 Prucalopride Sales Channels
7.4.2 Prucalopride Distributors
7.5 Prucalopride Customers
8 Prucalopride Market Dynamics
8.1 Prucalopride Industry Trends
8.2 Prucalopride Market Drivers
8.3 Prucalopride Market Challenges
8.4 Prucalopride Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Prucalopride Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Prucalopride Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Prucalopride Market Competitive Situation by Manufacturers in 2024
Table 4. Global Prucalopride Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Prucalopride Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Prucalopride Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Prucalopride Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Prucalopride Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Prucalopride, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Prucalopride, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Prucalopride, Product Type & Application
Table 12. Global Key Manufacturers of Prucalopride, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Prucalopride by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Prucalopride as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Prucalopride Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Prucalopride Sales by Region (2018-2023) & (K Units)
Table 18. Global Prucalopride Sales Market Share by Region (2018-2023)
Table 19. Global Prucalopride Sales by Region (2024-2034) & (K Units)
Table 20. Global Prucalopride Sales Market Share by Region (2024-2034)
Table 21. Global Prucalopride Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Prucalopride Revenue Market Share by Region (2018-2023)
Table 23. Global Prucalopride Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Prucalopride Revenue Market Share by Region (2024-2034)
Table 25. North America Prucalopride Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Prucalopride Sales by Country (2018-2023) & (K Units)
Table 27. North America Prucalopride Sales by Country (2024-2034) & (K Units)
Table 28. North America Prucalopride Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Prucalopride Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Prucalopride Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Prucalopride Sales by Country (2018-2023) & (K Units)
Table 32. Europe Prucalopride Sales by Country (2024-2034) & (K Units)
Table 33. Europe Prucalopride Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Prucalopride Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Prucalopride Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Prucalopride Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Prucalopride Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Prucalopride Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Prucalopride Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Prucalopride Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Prucalopride Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Prucalopride Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Prucalopride Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Prucalopride Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Prucalopride Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Prucalopride Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Prucalopride Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Prucalopride Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Prucalopride Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Prucalopride Sales (K Units) by Type (2018-2023)
Table 51. Global Prucalopride Sales (K Units) by Type (2024-2034)
Table 52. Global Prucalopride Sales Market Share by Type (2018-2023)
Table 53. Global Prucalopride Sales Market Share by Type (2024-2034)
Table 54. Global Prucalopride Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Prucalopride Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Prucalopride Revenue Market Share by Type (2018-2023)
Table 57. Global Prucalopride Revenue Market Share by Type (2024-2034)
Table 58. Global Prucalopride Price (US$/Unit) by Type (2018-2023)
Table 59. Global Prucalopride Price (US$/Unit) by Type (2024-2034)
Table 60. Global Prucalopride Sales (K Units) by Application (2018-2023)
Table 61. Global Prucalopride Sales (K Units) by Application (2024-2034)
Table 62. Global Prucalopride Sales Market Share by Application (2018-2023)
Table 63. Global Prucalopride Sales Market Share by Application (2024-2034)
Table 64. Global Prucalopride Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Prucalopride Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Prucalopride Revenue Market Share by Application (2018-2023)
Table 67. Global Prucalopride Revenue Market Share by Application (2024-2034)
Table 68. Global Prucalopride Price (US$/Unit) by Application (2018-2023)
Table 69. Global Prucalopride Price (US$/Unit) by Application (2024-2034)
Table 70. Takeda Corporation Information
Table 71. Takeda Description and Business Overview
Table 72. Takeda Prucalopride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. Takeda Prucalopride Product
Table 74. Takeda Recent Developments/Updates
Table 75. Johnson & Johnson Corporation Information
Table 76. Johnson & Johnson Description and Business Overview
Table 77. Johnson & Johnson Prucalopride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Johnson & Johnson Prucalopride Product
Table 79. Johnson & Johnson Recent Developments/Updates
Table 80. Apotex Corporation Corporation Information
Table 81. Apotex Corporation Description and Business Overview
Table 82. Apotex Corporation Prucalopride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. Apotex Corporation Prucalopride Product
Table 84. Apotex Corporation Recent Developments/Updates
Table 85. Jamp Pharma Corporation Corporation Information
Table 86. Jamp Pharma Corporation Description and Business Overview
Table 87. Jamp Pharma Corporation Prucalopride Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Jamp Pharma Corporation Prucalopride Product
Table 89. Jamp Pharma Corporation Recent Developments/Updates
Table 90. Key Raw Materials Lists
Table 91. Raw Materials Key Suppliers Lists
Table 92. Prucalopride Distributors List
Table 93. Prucalopride Customers List
Table 94. Prucalopride Market Trends
Table 95. Prucalopride Market Drivers
Table 96. Prucalopride Market Challenges
Table 97. Prucalopride Market Restraints
Table 98. Research Programs/Design for This Report
Table 99. Key Data Information from Secondary Sources
Table 100. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Prucalopride
Figure 2. Global Prucalopride Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Prucalopride Market Share by Type in 2024 & 2034
Figure 4. 1 mg Product Picture
Figure 5. 2 mg Product Picture
Figure 6. Global Prucalopride Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 7. Global Prucalopride Market Share by Application in 2024 & 2034
Figure 8. Offline Channel
Figure 9. Online Channel
Figure 10. Global Prucalopride Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 11. Global Prucalopride Market Size (2018-2034) & (US$ Million)
Figure 12. Global Prucalopride Sales (2018-2034) & (K Units)
Figure 13. Global Prucalopride Average Price (US$/Unit) & (2018-2034)
Figure 14. Prucalopride Report Years Considered
Figure 15. Prucalopride Sales Share by Manufacturers in 2024
Figure 16. Global Prucalopride Revenue Share by Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Prucalopride Players: Market Share by Revenue in 2024
Figure 18. Prucalopride Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 19. Global Prucalopride Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 20. North America Prucalopride Sales Market Share by Country (2018-2034)
Figure 21. North America Prucalopride Revenue Market Share by Country (2018-2034)
Figure 22. U.S. Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 23. Canada Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Europe Prucalopride Sales Market Share by Country (2018-2034)
Figure 25. Europe Prucalopride Revenue Market Share by Country (2018-2034)
Figure 26. Germany Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 27. France Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. U.K. Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. Italy Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Russia Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Asia Pacific Prucalopride Sales Market Share by Region (2018-2034)
Figure 32. Asia Pacific Prucalopride Revenue Market Share by Region (2018-2034)
Figure 33. China Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 34. Japan Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. South Korea Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. India Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. Australia Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Taiwan Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Indonesia Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Thailand Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Malaysia Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Philippines Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Latin America Prucalopride Sales Market Share by Country (2018-2034)
Figure 44. Latin America Prucalopride Revenue Market Share by Country (2018-2034)
Figure 45. Mexico Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 46. Brazil Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Argentina Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Middle East & Africa Prucalopride Sales Market Share by Country (2018-2034)
Figure 49. Middle East & Africa Prucalopride Revenue Market Share by Country (2018-2034)
Figure 50. Turkey Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 51. Saudi Arabia Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. UAE Prucalopride Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Global Sales Market Share of Prucalopride by Type (2018-2034)
Figure 54. Global Revenue Market Share of Prucalopride by Type (2018-2034)
Figure 55. Global Prucalopride Price (US$/Unit) by Type (2018-2034)
Figure 56. Global Sales Market Share of Prucalopride by Application (2018-2034)
Figure 57. Global Revenue Market Share of Prucalopride by Application (2018-2034)
Figure 58. Global Prucalopride Price (US$/Unit) by Application (2018-2034)
Figure 59. Prucalopride Value Chain
Figure 60. Prucalopride Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed